Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non-Human Primate Model of Multiple Sclerosis by Correcting Tissue Hypothyroidism

Journal of Neuroendocrinology

Volumn 23, Issue 9, 2011, Pages 778-790

  D'Intino, G ^a   Lorenzini, L ^a   Fernandez, M ^a   Taglioni, A ^b   Perretta, G ^b   Del Vecchio, G ^a   Villoslada, P ^c   Giardino, L ^a   Calza L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Experimental allergic encephalomyelitis; Marmoset; Oligodendrocyte precursor cells; Remyelination; Thyroid hormone

Indexed keywords

LIOTHYRONINE; MESSENGER RNA; THYROID HORMONE RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALLITRICHINAE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; HISTOPATHOLOGY; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; MORPHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIMATE; PRIORITY JOURNAL; REMYELINIZATION; SPINAL CORD;

ANIMALS; BIOLOGICAL MARKERS; CALLITHRIX; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; HYPOTHYROIDISM; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE REGENERATION; OLIGODENDROGLIA; STEM CELLS; THYROID HORMONES; TRIIODOTHYRONINE;

EID: 80051571769     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02181.x     Document Type: Article

References (59)

1. Stadelmann C, Wegner C, Bruck W. Inflammation, demyelination, and degeneration - recent insights from MS pathology. Biochim Biophys Acta 2011; 1812: 275-282.
2. McTigue DM, Tripathi RB. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 2008; 107: 1-19.
3. Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Höglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA 2007; 104: 4694-4699.
4. Wilson HC, Scolding NJ, Raine CS. Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. J Neuroimmunol 2006; 176: 162-173.
5. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Bruck W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008; 131: 1749-1758.
6. Lubetzki C, Williams A, Stankoff B. Promoting repair in multiple sclerosis: problems and prospects. Curr Opin Neurol 2005; 18: 237-2344.
7. Miller RH, Mi S. Dissecting demyelination. Nat Neurosci 2007; 10: 1351-1354.
8. Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest 2002; 25: 268-288.
9. Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004; 16: 809-818.
10. Horn S, Heuer H. Thyroid hormone action during development: more questions than answer. Mol Cell Endocrinol 2010; 315: 19-26.
11. O'Shea PJ, Williams GR. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J Endocrinol 2002; 175: 553-570.
12. Babu S, Sinha RA, Mohan V, Rao G, Pal A, Pathak A, Singh M, Godbole MM. Effect of hypothyroxinemia on thyroid hormone responsiveness and action during rat postnatal neocortical development. Exp Neurol 2011; 228: 91-98.
13. Baas D, Bourbeau D, Sarliève LL, Ittel ME, Dussault JH, Puymirat J. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 1997; 19: 324-332.
14. Fernández M, Pirondi S, Manservigi M, Giardino L, Calzà L. Thyroid hormone participates in the regulation of neural stem cells and oligodendrocyte precursor cells in the central nervous system of adult rat. Eur J Neurosci 2004; 20: 2059-2070.
15. Fernández M, Paradisi M, Del Vecchio G, Giardino L, Calzà L. Thyroid hormone induces glial lineage of primary neurospheres derived from non-pathological and pathological rat brain: implications for remyelination-enhancing therapies. Int J Dev Neurosci 2009; 27: 769-778.
16. Calzà L, Fernandez M, Giuliani A, Aloe L, Giardino L. Thyroid hormone activates oligodendrocyte precursors and increases a myelin-forming protein and NGF content in the spinal cord during experimental allergic encephalomyelitis. Proc Natl Acad Sci USA 2002; 99: 3258-3263.
17. Fernandez M, Giuliani A, Pirondi S, D'Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calzà L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci USA 2004; 101: 16363-16368.
18. Giardino L, Giuliani A, Fernandez M, Calzà L. Spinal motoneuron distress during experimental allergic encephalomyelitis. Neuropathol Appl Neurobiol 2004; 30: 522-531.
19. Calzà L, Fernandez M, Giardino L. Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J Mol Endocrinol 2010; 44: 13-23.
20. Pluchino S, Muzio L, Imitola J, Deleidi M, Alfaro-Cervello C, Salani G, Porcheri C, Brambilla E, Cavasinni F, Bergamaschi A, Garcia-Verdugo JM, Comi G, Khoury SJ, Martino G. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain 2008; 131: 2564-2578.
21. Franco PG, Silvestroff L, Soto EF, Pasquini JM. Thyroid hormones promote differentiation of remyelination after cuprizone-induced demyelination. Exp Neurol 2008; 212: 458-467.
22. Harsan LA, Steibel J, Zaremba A, Agin A, Sapin R, Poulet P, Guignard B, Parizel N, Grucker D, Boehm N, Miller RH, Ghandour MS. Recovery from chronic demyelination by thyroid hormone therapy: myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J Neurosci 2008; 28: 14189-14201.
23. Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J Exp Med 2000; 191: 1799-1806.
24. Pomeroy IM, Matthews PM, Frank JA, Jordan EK, Esiri MM. Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain 2005; 128: 2713-2721.
25. Kap YS, Laman JD, 't Hart BA. Experimental autoimmune encephalomyelitis in common marmoset, a bridge between rodent EAE and multiple sclerosis for immunotherapy development. J Neuroimmune Pharmacol 2010; 5: 220-230.
26. Mancardi G, Hart B, Roccatagliata L, Brok H, Giunti D, Bontrop R, Massacesi L, Capello E, Uccelli A. Demyelination and axonal damage in a non-human primate model of multiple sclerosis. J Neurol Sci 2001; 184: 41-49.
27. Pallinger E, Csaba G. A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells. Immunology 2008; 123: 584-589.
28. Klecha AJ, Klecha AJ, Genaro AM, Gorelik G, Barreiro Arcos ML, Silberman DM, Schuman M, Garcia SI, Pirola C, Cremaschi GA. Integrative study of hypothalamus-pituitary-thyroid-immune system interaction: thyroid hormone-mediated modulation of lymphocyte activity through the protein kinase C signaling pathway. J Endocrinol 2006; 189: 45-55.
29. Al-Abed Y, Metz CN, Cheng KF, Aljabari B, Vanpatten S, Blau S, Lee H, Ochani M, Pavlov VA, Coleman T, Meurice N, Tracey KJ, Miller EJ. Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity. Proc Natl Acad Sci USA 2011; 108: 224-8227.
30. Shenker M, Riederer BM, Kuntzer T, Barakat-Walter I. Thyroid hormones stimulate expression and modification of cytoskeletal protein during rat sciatic nerve regeneration. Brain Res 2002; 957: 259-270.
31. Trentin AG. Thyroid hormone and astrocyte morphogenesis. J Endocrinol 2006; 189: 189-197.
32. Reynolds R, Dawson M, Papadopulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 2002; 31: 523-536.
33. Calzà L, Giardino L, Pozza M, Bettelli C, Micera A, Aloe L. Proliferation and phenotype regulation in the subventricular zone during experimental encephalomyelitis in vivo evidence of a role for nerve growth factor. Proc Natl Acad Sci USA 1998; 95: 3209-3214.
34. Picard-Riera N, Decker L, Delrasse C, Goude K, Nait-Oumesmar B, Liblau R, Pham-Dinh D, Evercooren AB. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci USA 2002; 99: 13211-13216.
35. Jakovcevski I, Zecevic N. Olig transcription factors are expressed in oligodendrocyte and neuronal cells in human fetal CNS. J Neurosci 2005; 25: 10064-10073.
36. Emery B. Regulation of oligodendrocyte differentiation and myelination. Science 2010; 330: 779-782.
37. Arnett HA, Fancy SP, Alberta JA, Zhao C, Plant SR, Kaing S, Raine CS, Rowitch DH, Franklin RJ, Stiles CD. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS. Science 2004; 306: 2111-2115.
38. Tang DG, Tokumoto YM, Raff MC. Long-term culture of purified postnatal oligodendrocyte precursor cells. Evidence for an intrinsic maturation program that plays out over months. J Cell Biol 2000; 148: 971-984.
39. Durand B, Raff M. A cell-intrinsic timer that operates during oligodendrocyte development. BioAssays 2000; 22: 64-71.
40. Baas D, Legrand C, Samarut J, Flamant F. Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors. Proc Natl Acad Sci USA 2002; 99: 2907-2911.
41. Dong H, Yauk CL, Rowan-Carroll A, You S-E, Zoeller T, Lambert I, Wade MG. Identification of thyroid hormone receptor binding sites and target genes using ChIP-on-Chip in developing mouse cerebellum. PLoS ONE 2009; 4: e4610.
42. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38-89.
43. Cheng S-Y, Leonard JL, Davis PJ. Molecular aspects of thyroid hormone actions. Endocr Rev 2010; 31: 139-170.
44. Koenig RJ. Modeling the nonthyroidal illness syndrome. Curr Opin Endocrinol Diabetes Obes 2008; 15: 466-469.
45. Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol 2010; 205: 1-13.
46. Boelen A, Kwakkel J, Wiersinga WM, Fliers E. Chronic local inflammation in mice results in decreased TRH and type 3 deiodinase mRNA expression in the hypothalamic paraventricular nucleus independently of diminished food intake. J Endocrinol 2006; 191: 707-714.
47. Vercellino M, Masera S, Lorenzatti M, Condello C, Merola A, Mattioda A, Tribolo A, Capello E, Mancardi GL, Mutani R, Giordana MT, Cavalla P. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68: 489-502.
48. Baur A, Bauer K, Jarry H, Köhrle J. Effects of proinflammatory cytokines on anterior pituitary 5'-deiodinase type I and type II. J Endocrinol 2000; 167: 505-515.
49. Kwakkel J, Wiersinga WM, Boelen A. Differential involvement of nuclear factor-kappaB and activator protein-1 pathways in the interleukin-1beta-mediated decrease of deiodinase type 1 and thyroid hormone receptor beta1 mRNA. J Endocrinol 2006; 189: 37-44.
50. Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C, Kacskovics I, Larsen PR. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 2004; 145: 1649-1655.
51. Margaill I, Royer J, Lerouet D, Raumagé M, Le Goascogne C, Li WW, Plotkine M, Pierre M, Courtin F. Induction of type 2 iodothyronine deiodinase in astrocytes after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 2005; 25: 468-476.
52. Boelen A, Mikita J, Boiziau C, Chassande O, Fliers E, Petry KG. Type 3 deiodinase expression in inflammatory spinal cord lesions in rat experimental autoimmune encephalomyelitis. Thyroid 2009; 19: 1401-1406.
53. Boelen A, Kwakkel J, Platvoet-ter Schphorst M, Boelen A. Interleukin-18, a proinflammatory cytokine, contributes to the pathogenesis of non-thyroidal illness mainly via the central part of the hypothalamus-pituitary-thyroid axis. Eur J Endocrinol 2004; 151: 497-502.
54. Kwakkel J, Wiersinga WM, Boelen A. Interleukin-1beta modulates endogenous thyroid hormone receptor alpha gene transcription in liver cells. J Endocrinol 2007; 194: 257-265.
55. Lado-Abeal J, Romero A, Castro-Piedras I, Rodriguez-Perez A, Alvarez-Escudero J. Thyroid hormone receptors are down-regulated in skeletal muscle of patients with non-thyroidal illness syndrome secondary to non-septic shock. Eur J Endocrinol 2010; 163: 765-773.
56. Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L, Darras VM, Fliers E, Visser TJ, Van den Berghe G. Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness. Crit Care 2009; 13: R147.
57. Zych-Twardowska E, Wajgt A. Blood levels of selected hormones in patients with multiple sclerosis. Med Sci Monit 2001; 7: 1005-1012.
58. Jiang Y, Yang Y, Zhang B, Peng F, Bao J, Hu X. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica. Neuroendocrinol Lett 2009; 30: 85-90.
59. Han MH, Hwang S-II, Roy DB, Lundgren DH, Price JV, Ousman SS, Fernald GH, Gerlitz B, Robinson WH, Baranzini SE, Grinnell BW, Raine CS, Sobel RA, Han DK, Steinman L. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature 2008; 451: 1076-1081.